Monday

Innovation in action: moving forward with basal insulins in T2D

Understanding and Preventing Hypoglycemia in Diabetes

CGM as an Essential Companion Across Diabetes Management

People, Populations and Practice: Exploring the Journey across Diabetes care

The turning tide of a rapidly evolving obesity landscape

Emerging therapies in heart and kidney disease: Effects and clinical implications of finerenone

The three Gs in the context of gut hormone multiagonism

Thinking together: learnings from 3-real life cases to improve diabetes management and transform your clinical practice with CGM

The Kidney in Focus in Diabetes Care – Novel Strategies for Changing CKD Trajectory

Optimising Cardiorenal Outcomes Through Early Initiation of SGLT2 Inhibitors

Expanding Horizons in Insulin Therapy: Applications of MiniMed™ 780G system and MDI solutions

Prepare, Prevent & Act: Unlocking the power of prediction for advanced in-time glycaemic control

The glucagon philharmonic: Orchestrating metabolic harmony in obesity, liver disease and health

The Heart in Focus in Obesity Care – Lowering the CV Burden with Novel Weight Loss Therapies

Exploring therapeutic mechanisms to improve organ function in CVRM diseases

iCan real time CGM system, an option for all patient groups

Redefining T2D and Obesity Management: The First and Only Approved Dual GIP and GLP-1 Receptor Agonist

Expert Insights on the Value of Protection Against Vaccine-Preventable Disease in Patients with Diabetes

Triple protection of SGLT2i: ACT2DAY for patients’ future

Tuesday

AI-assisted screening for diabetic retinopathy – real-life outcomes

Beta-cell dysfunction in T2D – is it irrevocable?

Hot Topic Session – Abbott

Hot Topic Session – Sciarc GmbH

The right time for Metformin

Improving adherence, glycemic control and outcomes for people living with diabetes

At the crossroads of specialties: Exploring the trends in the holistic, person-centred approach in cardiovascular-kidney-metabolic disease

Wednesday

Conversations between specialties: the importance of SGLT2 inhibitor initiation for the interdisciplinary management of cardio, renal and metabolic conditions

Industry symposium – Insulet

Industry symposium – Abbott

A New Technological Horizon: Optimizing Treatment with Tandem Diabetes Care

T2D care in the digital era: ​evidence with once-weekly insulins, CGM and other digital health tools​

Overcoming clinical inertia in Type 2 diabetes with Dexcom CGM

The need to look beyond BMI

Industry symposium – Sciarc GmbH

Obesity management in the spotlight: how can we achieve patient-centricity? ​

Embracing innovation in a new era of diabetes care: A CME Symposium

From Burden to Breakthrough: Reimagining Type 1 Diabetes Treatment With Cell-Based Approaches

Thursday

Addressing the needs of all people living with type 1 diabetes

AI-based glucose predictions – bringing diabetes self-management to the next level

Breaking the barriers: Addressing the metabolic impact of MASH with multidisciplinary care

Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies 

Cholesterol Lowering in High Cardiovascular Risk Patients with Comorbidities: Closing Gaps and Future Opportunities

Management of CKD in T2D – where are we today?

Friday

Multidisciplinary dialogue on non-invasive liver assessment in patients with obesity: from guidelines to clinical research

Enabling women with type 1 diabetes to achieve their goals with Automated Insulin Delivery